Year-End Report 20/21
September 2020 – August 2021, Diamyd Medical AB (publ), Fiscal year 2020/2021Developing Precision Medicine Therapies for Type 1 DiabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com
Figures in parentheses relate to the corresponding period previous financial year.
September 1, 2020 – August 31, 2021
· Net result: MSEK 60.0 (9.7), fourth quarter -27.4 (-13.5). Profit from divestment of shares in Companion Medical, Inc. during the year improved the net result by MSEK 144.